7 unknown. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 7 |
Follow Sintilimab: new trials by email Literature Review of Sintilimab trials Research Report on Sintilimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma sintilimab, Trastuzumab, S-1 plus oxaliplatin - HER2-positive, Locally Advanced Solid Tumor | Phase 2 | Unknown | Aiping Zhou | 44 | 2022-04-01 | 2022-04-06 |
| Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer Sintilimab, S-1, Oxaliplatin - Gastric Cancer, Perioperative | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 210 | 2021-06-21 | 2021-08-31 |
| A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer Sintilimab, Cisplatin, External Beam Radiotherapy (EBRT) - Uterine Cervical Neoplasms, Sintilimab | Phase 2 | Unknown | The Affiliated Hospital of Xuzhou Medical University | 20 | 2021-03-08 | 2021-12-28 |
| Sintilimab in FH-deficient Renal Cell Carcinoma Sintilimab - Renal Cell Carcinoma, FH-deficient | Phase 2 | Unknown | West China Hospital | 37 | 2020-06-01 | 2020-05-12 |
| Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma. Sintilimab-R-CHOP - Diffuse Large B-Cell Lymphoma, Sintilimab | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 30 | 2019-12-01 | 2019-12-11 |
| SRS Sequential Sindilimab in Brain Metastasis of NSLSC SRS sequential sintilimab - NSCLC Stage IV, Brain Metastases | Phase 2 | Unknown | Xiaorong Dong | 25 | 2019-11-01 | 2019-11-27 |
| Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer sintilimab - Brain Metastases, Non Small Cell Lung Cancer | Phase 2 | Unknown | Sun Yat-sen University | 60 | 2019-04-29 | 2019-12-30 |
Brain Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Stomach Neoplasms (1) · Uterine Cervical Neoplasms (1)
Neoplasms (6) · Neoplasms by Site (5) · Brain Diseases (2) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms by Histologic Type (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Respiratory Tract Diseases (2)
sintilimab (5) · Oxaliplatin (2) · S 1 (combination) (2) · Bevacizumab (1) · Brachytherapy (1) · Cisplatin (1) · Trastuzumab (1)
Aiping Zhou (1) · Chinese Academy of Medical Sciences (1) · Sun Yat-sen University (1) · The Affiliated Hospital of Xuzhou Medical University (1) · Tianjin Medical University Cancer Institute and Hospital (1) · West China Hospital (1) · Xiaorong Dong (1)
China (5)
Han Liang, PhD. (1) · Likun Chen, doctor (1) · Longzhen Zhang, MD (1) · Xuewei Ding, PhD. (1) · Yuankai Shi, M.D (1)